Disc Medicine Inc (NASDAQ:IRON) currently has a daily average trading volume of 461.06K but it saw 347423 shares traded in last market. With a market cap of 1.46B USD, the company’s current market price of $42.17 came rising about 2.84 while comparing to the previous closing price of $41.00. In past 52 weeks, the stock remained buoying in the range of price level as high as $68.73 and as low as $25.64. In the recent trading on the day, stock has struck highest price mark of $40.69 while lowest mark touched by it was $42.46.
Taking a look at 20-day trading activity of Disc Medicine Inc (IRON) gives us an average price of $44.96, while its current price level is -38.65% below from 52-week high level whereas it is 64.43% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $50.51 while that of 200 days or SMA-200 reads an average of $52.65. A closer look into the stock’s movement over the week reveals that its volatility is standing at 6.45% during that period while stretching the period over a month that increases to 8.99%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 42.98 which implies that the stock is in neutral territory.
Morgan Stanley upgraded its recommendation for the stock as a “Overweight” from “Equal-Weight” on November 05, 2024 while assigning a price target of $85. Raymond James issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $66 and $110.
Over the week, IRON’s stock price is moving 19.68% up while it is -21.54% when we observe its performance for the past one month. Year-to-date it is -33.49% down and over the past year, the stock is showing an upside performance of 40.88%.
The company is expected to be releasing its next quarterly report on 2025-Feb-26, for which analysts forecasted an EPS of -1.07 while estimate for next year EPS is -4.89.
Currently, Disc Medicine Inc’s total number of outstanding shares is 29.87M with 11.32% of that held by the insiders while 79.49% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -23.10% and return on equity (ROE) at -27.73%. Stock’s beta reads 0.84. Stock has a price to book (P/B) ratio of 2.84. Its return on asset (ROA) is -25.29% on average.
